Zuckerberg支持的Biohub牵头18亿美元计划，建设可预测细胞行为的AI模型

AI models are supposed to learn to predict cell behavior, which could speed up drug development. Biohub, the nonprofit backed by Mark Zuckerberg and Priscilla Chan, is coordinating a $1.8 billion effort spanning data, lab equipment, and compute, Reuters reports. The group had already pledged $500 million in April for its five-year "Virtual Biology Initiative." Meta, Google DeepMind, and Isomorphic Labs are contributing a combined $300 million, while the US Department of Energy is investing over $500 million in lab measurements and compute over five years. The National Institutes of Health are coordinating datasets built with more than $500 million in prior federal funding, and Biohub will standardize them for AI training.

Commercial funders get one year of exclusive access to the data they paid for before it goes public, according to Biohub research lead Alex Rives. Government-funded work will be available without those restrictions. A first dataset should be ready in about a year.

Other AI companies are also pursuing biology projects. Anthropic has built its own biology lab for AI-driven drug development, and the OpenAI Foundation is putting more than $125 million toward biological and medical datasets.

AI News Without the Hype – Curated by Humans

Subscribe to THE DECODER for ad-free reading, a weekly AI newsletter, our exclusive "AI Radar" frontier report six times a year, full archive access, and access to our comment section.